Aveanna Healthcare (NASDAQ:AVAH) Trading Up 4.5% – Should You Buy?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) was up 4.5% during trading on Tuesday . The stock traded as high as $5.30 and last traded at $5.29. Approximately 100,827 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 186,476 shares. The stock had previously closed at $5.06.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft upped their target price on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research note on Friday, August 9th. UBS Group increased their price objective on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a research report on Friday, August 9th. Finally, Royal Bank of Canada lifted their target price on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “sector perform” rating in a research report on Friday, August 9th.

Aveanna Healthcare Trading Down 0.7 %

The business has a 50-day moving average price of $5.18 and a 200 day moving average price of $3.63. The stock has a market capitalization of $1.04 billion, a P/E ratio of -9.03 and a beta of 2.12.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. The company had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. On average, sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post -0.09 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in AVAH. Littlejohn & Co. LLC boosted its position in Aveanna Healthcare by 7.4% during the first quarter. Littlejohn & Co. LLC now owns 8,377,258 shares of the company’s stock worth $20,859,000 after purchasing an additional 578,488 shares in the last quarter. Vanguard Group Inc. raised its position in Aveanna Healthcare by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after purchasing an additional 44,970 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of Aveanna Healthcare by 155.8% during the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after buying an additional 96,600 shares during the period. Bank of New York Mellon Corp lifted its position in shares of Aveanna Healthcare by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after purchasing an additional 9,243 shares during the last quarter. Finally, Acadian Asset Management LLC grew its stake in shares of Aveanna Healthcare by 176.6% during the second quarter. Acadian Asset Management LLC now owns 81,275 shares of the company’s stock worth $222,000 after purchasing an additional 51,890 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.